HHS Nominee Leavitt Wants To "Learn More" About Rx Imports
This article was originally published in The Pink Sheet Daily
Executive Summary
Michael Leavitt tells Senate Finance Committee during confirmation hearing that he has read "conflicting views" on the economic benefits of drug importation. Leavitt also notes that as HHS Secretary, importation safety issues would fall "squarely" on his desk.